Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation

被引:99
作者
Humaidan, P [1 ]
Bungum, L
Bungum, M
Andersen, CY
机构
[1] Skive Sygehus, Fertil Clin, DK-7800 Skive, Denmark
[2] Univ Copenhagen Hosp, Sect 5712, Reprod Biol Lab, DK-2100 Copenhagen, Denmark
关键词
GnRH agonist; IVF; luteinizing hormone; ovarian response; pituitary suppression;
D O I
10.1093/humrep/17.8.2016
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The effect of LH levels on stimulation day 8 on ovarian response and pregnancy outcome were evaluated in women receiving pituitary down-regulation with GnRH agonists (0.8 mg Suprefact(R) s.c. daily until pituitary down-regulation and 0.4 mg/day during ovarian stimulation) and ovarian stimulation with recombinant FSH. METHODS: Blood samples were prospectively collected from a total of 207 normal women undergoing assisted reproduction and analysed retrospectively. Based on LH levels on stimulation day 8 patients were divided into four groups: <0.5, 0.51-1.0, 1.01-1.5, >1.51 IU/l. RESULTS: Estradiol levels on day 8 and estradiol per oocyte retrieved showed a highly significant correlation with LH concentrations on day 8. The total consumption of exogenous FSH and duration of gonadotrophin stimulation was inversely related to LH levels on day 8 (P < 0.002). The frequencies of fertilization and clinical pregnancies were superior in the two middle groups. Only 12% of the patients showed LH levels <0.5 IU/l, which, however, may be explained by the particular mode and doses of GnRH agonist used. CONCLUSIONS: Circulating levels of LH on day 8 have a significant impact on ovarian response and pregnancy outcome. LH should neither be too high nor too low. The mode of administration and the dose of the GnRH agonist used may determine the number of women who experience LH levels below 0.5 IU/l.
引用
收藏
页码:2016 / 2021
页数:6
相关论文
共 23 条
[1]  
[Anonymous], 1998, J Clin Endocrinol Metab, V83, P1507
[2]   THE ROLE OF LUTEINIZING-HORMONE IN HUMAN FOLLICLE DEVELOPMENT AND OOCYTE FERTILITY - EVIDENCE FROM IN-VITRO FERTILIZATION IN A WOMAN WITH LONG-STANDING HYPOGONADOTROPIC HYPOGONADISM AND USING RECOMBINANT HUMAN FOLLICLE-STIMULATING-HORMONE [J].
BALASCH, J ;
MIRO, F ;
BURZACO, I ;
CASAMITJANA, R ;
CIVICO, S ;
BALLESCA, JL ;
PUERTO, B ;
VANRELL, JA .
HUMAN REPRODUCTION, 1995, 10 (07) :1678-1683
[3]   Suppression of LH during ovarian stimulation:: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH [J].
Balasch, J ;
Vidal, E ;
Peñarrubia, J ;
Casamitjana, R ;
Carmona, F ;
Creus, M ;
Fábregues, F ;
Vanrell, JA .
HUMAN REPRODUCTION, 2001, 16 (08) :1636-1643
[4]   Successful induction of ovulation using highly purified follicle-stimulating hormone in a woman with Kallmann's syndrome [J].
Battaglia, C ;
Salvatori, M ;
Regnani, G ;
Giulini, S ;
Primavera, MR ;
Volpe, A .
FERTILITY AND STERILITY, 2000, 73 (02) :284-286
[5]   REEVALUATION OF THE ROLES OF LUTEINIZING-HORMONE AND FOLLICLE-STIMULATING-HORMONE IN THE OVULATORY PROCESS [J].
CHAPPEL, SC ;
HOWLES, C .
HUMAN REPRODUCTION, 1991, 6 (09) :1206-1212
[6]   FOLLICLE-STIMULATING-HORMONE VERSUS HUMAN MENOPAUSAL GONADOTROPIN FOR IN-VITRO FERTILIZATION CYCLES - A METAANALYSIS [J].
DAYA, S ;
GUNBY, J ;
HUGHES, EG ;
COLLINS, JA ;
SAGLE, MA .
FERTILITY AND STERILITY, 1995, 64 (02) :347-354
[7]   Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone [J].
Esposito, MA ;
Barnhart, KT ;
Coutifaris, C ;
Patrizio, P .
FERTILITY AND STERILITY, 2001, 75 (03) :519-524
[8]  
FALCK B, 1959, ACTA PHYSIOL SCAND, V47, P1
[9]  
Fanchin R, 2001, HUM REPROD, V16, P14
[10]   Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome [J].
Filicori, M ;
Cognigni, GE ;
Taraborrelli, S ;
Spettoli, D ;
Ciampaglia, W ;
de Fatis, CT ;
Pocognoli, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08) :2659-2663